doi:10.3969/j.issn.1004-583X.2025.01.012

Abstract

CLC Number:

R587.24

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2025.01.012

https://huicui.hebmu.edu.cn/EN/Y2025/V40/I1/76

References 51

[1]	Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119.
[2]	Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2020, 162:108072.
[3]	Darraj A. The link between sleeping and type 2 diabetes: A systematic review[J]. Cureus, 2023, 15(11):e48228.
[4]	Cohen-Solal M, Funck-Brentano T, Ureña Torres P. Bone fragility in patients with chronic kidney disease[J]. Endocr Connect, 2020, 9(4):R93-R101.
[5]	Sateia MJ. International classification of sleep disorders-third edition: Highlights and modifications[J]. Chest. 2014, 146(5):1387-1394. doi: S0012-3692(15)52407-0 pmid: 25367475
[6]	罗婷, 陈利群, 李正荣, 等. 糖尿病肾病维持性血液透析患者情绪障碍及影响因素回顾性研究[J]. 重庆医科大学学报, 2020, 45(10):1421-1425.
[7]	Koopman ADM, Beulens JW, Dijkstra T, et al. Prevalence of insomnia (symptoms) in T2D and association with metabolic parameters and glycemic control: Meta-analysis[J]. J Clin Endocrinol Metab, 2020, 105(3):614-643.
[8]	Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: Epidemiology of kidney disease in the United States[J]. Am J Kidney Dis, 2019, 73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001 pmid: 30798791
[9]	Lambourg E, Colvin L, Guthrie G, et al. The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis[J]. Kidney Int, 2021, 100(3):636-649. doi: 10.1016/j.kint.2021.03.041 pmid: 33940112
[10]	Mather KJ, Bebu I, Baker C, et al. GRADE Research Group. Prevalence of microvascular and macrovascular disease in the glycemia reduction approaches in diabetes-A Comparative Effectiveness (GRADE) study cohort[J]. Diabetes Res Clin Pract, 2020, 165:108235.
[11]	周吉, 冉玉力, 廖雪娇, 等. 单中心维持性血液透析患者睡眠状况及影响因素分析[J]. 新疆医学, 2024, 54(2):189-192.
[12]	Kuo CP, Lu SH, Huang CN, et al. Sleep quality and associated factors in adults with type 2 diabetes: A retrospective cohort study[J]. Int J Environ Res Public Health, 2021, 18:6.
[13]	蔡银香, 杨雪球, 姜俊, 等. 慢性肾脏病患者睡眠障碍的相关因素分析[J]. 安徽医科大学学报, 2024, 59(3):521-526.
[14]	Birhanu TT, Hassen Salih M, Abate HK. Sleep quality and associated factors among diabetes mellitus patients in a follow-up clinic at the university of Gondar comprehensive specialized hospital in Gondar, Northwest Ethiopia: A cross-sectional study[J]. Diabetes Metab Syndr Obes, 2020, 13:4859-4868.
[15]	Zou Y, Yang Q, Lang Y, et al. The prognostic impact of the stress hyperglycemia ratio on end-stage renal disease among patients with diabetic kidney disease[J]. Diabetes Obes Metab, 2025, 27(2):629-641.
[16]	冯晓楠, 栾凤武, 田娜, 等. 血液透析患者睡眠障碍的影响因素研究[J]. 宁夏医学杂志, 2021, 43(9):808-810.
[17]	张艳, 梁亚萍, 孙铭薇, 等. 老年人衰弱的影响因素分析[J] .中华疾病控制杂志, 2019, 23(2): 140-145.
[18]	Perfect MM. Sleep-related disorders in patients with type 1 diabetes mellitus: Current insights[J]. Nat Sci Sleep, 2020, 12:101. doi: 10.2147/NSS.S152555 pmid: 32104119
[19]	Bayrak M, Çadirci K. Quality of sleep in elderly patients with diabetes mellitus from Turkey: A cross-sectional observational study[J]. Exp Aging Res, 2021, 48:1-14. doi: 10.1080/0361073X.2021.1989929 pmid: 34635033
[20]	Kioskli K, Scott W, Winkley K, et al. Psychosocial factors in painful diabetic neuropathy: A systematic review of treatment trials and survey studies[J]. Pain Medicine, 2019, 20:1756-1773. doi: 10.1093/pm/pnz071 pmid: 30980660
[21]	Kalantar-Zadeh K, Lockwood MB, Rhee CM, et al. Patient-cen-tred approaches for the management of unpleasant symptoms in kidney disease[J]. Nat Rev Nephrol, 2022, 18(3) :185-198. doi: 10.1038/s41581-021-00518-z pmid: 34980890
[22]	Barikani A, Javadi M, Rafiei S. Sleep quality and blood lipid composition among patients with diabetes[J]. Int J Endocrinol Metab, 2019, 17(3):e81062.
[23]	Kalaitzidis RG, Theofilis P, Touchantzidou K, et al. Chronic pain and its association with depressive symptoms and renal function in hypertensive patients[J]. Int J Environ Res Public Health, 2022, 19(3):1899.
[24]	Marzouq MK, Samoudi AF, Samara A, et al. Exploring factors associated with pain in hemodialysis patients: A multicenter cross-sectional study from Palestine[J]. BMC Nephrol. 2021, 17;22(1):96.
[25]	Molsted S, Eidemak I. Musculoskeletal pain reported by mobile patients with chronic kidney disease[J]. Clin Kidney J, 2020, 13(5):813-820. doi: 10.1093/ckj/sfz196 pmid: 33123357
[26]	高胜男, 张冉冉, 张羽曦, 等. 我国糖尿病神经病理性疼痛疾病负担及药物治疗进展[J]. 临床荟萃, 2024, 39(9): 842-846.
[27]	Lu Y, Xing P, Cai X, et al. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: Estimates of the INTERPRET-DD study[J]. Front Public Health, 2020, 8:534372.
[28]	Xue P, Covassin N, Ran X, et al. Association of parameters of nocturnal hypoxemia with diabetic microvascular complications: A cross-sectional study[J]. Diabetes Res Clin Pract, 2020, 170:108484.
[29]	李钟梅, 冉丽, 蒋依, 等. 老年轻度认知障碍患者睡眠障碍与认知功能的关系[J]. 临床荟萃, 2022, 37(7): 607-611.
[30]	Li X, Chattopadhyay K, Qian X, et al. Association between sleep duration and albuminuria in patients with type 2 diabetes: A cross-sectional study in Ningbo, China[J]. Diabetes Metab Syndr Obes, 2022, 15:1667-1675.
[31]	Labarca G, Dreyse J, Salas C, et al. Risk of mortality among patients with moderate to severe obstructive sleep apnea and diabetes mellitus: Results from the SantOSA cohort[J]. Sleep Breath, 2021, 25(3):1467-1475. doi: 10.1007/s11325-020-02283-y pmid: 33394326
[32]	Shen Y, Chen Y, Huang S, et al. The association between symptoms of depression and anxiety, quality of life, and diabetic kidney disease among Chinese adults: A cross-sectional study[J]. Int J Environ Res Public Health, 2022, 20(1):475.
[33]	郭正勇, 赵观进, 张慧泽, 等. 睡眠时间和糖尿病肾脏疾病尿蛋白进展风险的前瞻性队列研究[J]. 实用医学杂志, 2021, 37(17): 2282-2286.
[34]	Komici K, Femminella GD, de Lucia C, et al. Predisposing factors to heart failure in diabetic nephropathy: A look at the sympathetic nervous system hyperactivity[J]. Aging Clinical and Experimental Research, 2019, 31: 321-330. doi: 10.1007/s40520-018-0973-2 pmid: 29858985
[35]	Huang S, Yao X, Chen X, et al. Metabolic syndrome and socioeconomic status in association with chronic kidney disease: A cross-sectional study in Ningbo, China[J]. Diabetes Metab Syndr Obes, 2024, 17:3891-3901.
[36]	Dos Santos PR, Mendonça CR, Hernandes JC, et al. Pain in patients with chronic kidney disease undergoing hemodialysis: A systematic review[J]. Pain Manag Nurs, 2021, 22(5):605-615. doi: 10.1016/j.pmn.2021.05.009 pmid: 34217608
[37]	Hicks CW, Wang D, Matsushita K, et al. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. Adults: A prospective cohort study[J]. Ann Intern Med, 2021, 174(2): 167-174.
[38]	Kim J, Padanilam BJ. Renal denervation prevents long-term sequelae of ischemic renal injury[J]. Kidney international, 2015, 87(2): 350-358. doi: 10.1038/ki.2014.300 pmid: 25207878
[39]	Mathis KW, Venegas-Pont M, Flynn ER, et al. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves[J]. Am J Physiol Regul Integr Comp Physiol, 2013, 305(7): R711-R719.
[40]	Gregg LP, Carmody T, Le D, et al. A systematic review and meta-analysis of depression and protein-energy wasting in kidney disease[J]. Kidney Int Rep, 2020, 5(3): 318-330. doi: 10.1016/j.ekir.2019.12.009 pmid: 32154453
[41]	Chen Y, Kanwar YS, Chen X, et al. Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications[J]. Curr Med Chem, 2024, 31(6):697-725.
[42]	Yoshikawa F, Shigiyama F, Ando Y, et al. Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia[J]. Diabetes Res Clin Pract, 2020, 169:108412.
[43]	区敏. 右佐匹克隆治疗2型糖尿病伴失眠80例疗效观察探究实践[J]. 医药前沿, 2021, 11(6):91-92.
[44]	Xie Z, Chen F, Li WA, et al. A review of sleep disorders and melatonin[J]. Neurol Res, 2017, 39: 559-565. doi: 10.1080/01616412.2017.1315864 pmid: 28460563
[45]	Wajid F, Poolacherla R, Mim FK, et al. Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus[J]. J Diabetes Metab Disord, 2020, 19:1797-1825.
[46]	Yang X, Yang J, Yang C, et al. Continuous positive airway pressure can improve depression in patients with obstructive sleep apnoea syndrome: A meta-analysis based on randomized controlled trials[J]. J Int Med Res, 2020, 48(3):300060519895096.
[47]	Kothari V, Cardona Z, Chirakalwasan N, et al. Sleep interventions and glucose metabolism: Systematic review and meta-analysis[J]. Sleep Med, 2021, 78:24-35. doi: 10.1016/j.sleep.2020.11.035 pmid: 33383394
[48]	McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol-a review[J]. Br J Clin Pharmacol, 2018, 84(10):2218-2230. doi: 10.1111/bcp.13656 pmid: 29863746
[49]	Zhan M, Doerfler RM, Xie D, et al. Association of opioids and nonsteroidal anti-inflammatory drugs with outcomes in CKD: Findings from the CRIC (Chronic Renal Insufficiency Cohort) study[J]. Am J Kidney Dis, 2020, 76(2):184-193. doi: S0272-6386(20)30042-1 pmid: 32317121
[50]	中国医师协会神经内科医师分会疼痛和感觉障碍专委会. 糖尿病性周围神经病理性疼痛诊疗专家共识[J]. 全科医学临床与教育, 2019, 17(2):100-103, 107.
[51]	Chan KW, Smeijer JD, Schechter M, et al. Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease[J]. Kidney Int, 2023, 104(6):1219-1226. doi: 10.1016/j.kint.2023.08.014 pmid: 37657768

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 51

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Jiawen, Liu Yanlan, Li Yaoshuang, Qiu Huina, Li Fang, Wu Fan, Lin Chenying, Lin Jingna. Association of TyG index and its derivatives with the risk of diabetic kidney disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(10): 901-908.
[2]	Wang Chunjie, Xie Jing, Han Xue, Wu Dan, Chen Jianhua. Effect of individualized hemodialysis on dialysis complications in elderly patients with diabetic nephropathy [J]. Clinical Focus, 2024, 39(4): 332-336.
[3]	. [J]. Clinical Focus, 2023, 38(6): 564-568.
[4]	Li Huifang, Miao Xia. Prediction of thyroid hormone level on risk of type 2 diabetes nephropathy [J]. Clinical Focus, 2023, 38(2): 137-142.
[5]	He Feng, Nin Lu, Luo Gao, Yang Ruifei, Li Fanfan, Cheng Xiaoqiong, An Binbin, Li Jingjuan, Liu Yuanyuan, Guo Qian, Wang Jinyang. Correlation of Chinese visceral adipose index and visceral fat area with diabetic nephropathy and their warning values [J]. Clinical Focus, 2022, 37(12): 1089-1093.
[6]	Yao Yao, Chu Min. Relationship between serum amyloid β-protein and cognitive dysfunction in patients with diabetic kidney disease [J]. Clinical Focus, 2022, 37(9): 813-816.
[7]	. [J]. Clinical Focus, 2022, 37(5): 467-471.
[8]	Gao Shixin, Song Bing, Shi Kexin. Diagnosis value of serum lipoprotein α, cystatin-C and uric acid on early diabetic nephropathy [J]. Clinical Focus, 2022, 37(3): 248-252.
[9]	. [J]. Clinical Focus, 2022, 37(2): 178-181.
[10]	Liu Lunzhi, Deng Lu, Zhang Mingxia. Effects of angiotensin Ⅱ type 1 receptor blockers on urinary nephrin and Beclin-1 mRNA excretion in urine of patients with early diabetic nephropathy [J]. Clinical Focus, 2021, 36(11): 1005-1008.
[11]	. [J]. Clinical Focus, 2021, 36(11): 1029-1033.
[12]	. [J]. Clinical Focus, 2021, 36(11): 1034-1040.
[13]	Liu Meng, Hu Guicai, Yang Zongna, Guo Weiwei, Chen Wanxin. Comparative study on volume load and nutritional status in hemodialysis patients with diabetic kidney disease and non-diabetic kidney disease [J]. Clinical Focus, 2021, 36(4): 332-335.
[14]	Wang Chunhua. Effect of alprostadil combined with Sanqi Panax Notoginseng Injection on proteinuria in early diabetic nephropathy [J]. Clinical Focus, 2015, 30(12): 1410-1412.
[15]	. [J]. Clinical Focus, 2015, 30(6): 715-717718.